Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

Deep brain stimulation for the treatment of drug addiction.

Wang TR, Moosa S, Dallapiazza RF, Elias WJ, Lynch WJ.

Neurosurg Focus. 2018 Aug;45(2):E11. doi: 10.3171/2018.5.FOCUS18163.

PMID:
30064320
2.

A 7-year observation of the effect of subthalamic deep brain stimulation on impulse control disorder in patients with Parkinson's disease.

Kim A, Kim YE, Kim HJ, Yun JY, Yang HJ, Lee WW, Shin CW, Park H, Jung YJ, Kim A, Ehm G, Kim Y, Jang M, Jeon B.

Parkinsonism Relat Disord. 2018 Jul 20. pii: S1353-8020(18)30313-4. doi: 10.1016/j.parkreldis.2018.07.010. [Epub ahead of print]

PMID:
30054182
3.
4.

Psychological functioning in Parkinson's disease post-deep brain stimulation: Self-regulation and executive functioning.

Combs HL, Garcia-Willingham NE, Berry DTR, van Horne CG, Segerstrom SC.

J Psychosom Res. 2018 Aug;111:42-49. doi: 10.1016/j.jpsychores.2018.05.007. Epub 2018 May 21.

PMID:
29935753
5.

Informed Consent Decision-Making in Deep Brain Stimulation.

Mandarelli G, Moretti G, Pasquini M, Nicolò G, Ferracuti S.

Brain Sci. 2018 May 11;8(5). pii: E84. doi: 10.3390/brainsci8050084. Review.

6.

Deep Brain Stimulation of the Internal Globus Pallidus Improves Response Initiation and Proactive Inhibition in Patients With Parkinson's Disease.

Pan Y, Wang L, Zhang Y, Zhang C, Qiu X, Tan Y, Zhou H, Sun B, Li D.

Front Psychol. 2018 Apr 6;9:351. doi: 10.3389/fpsyg.2018.00351. eCollection 2018.

7.

Subthalamic nucleus stimulation, dopaminergic treatment and impulsivity in Parkinson's disease.

Fluchère F, Burle B, Vidal F, van den Wildenberg W, Witjas T, Eusebio A, Azulay JP, Hasbroucq T.

Neuropsychologia. 2018 Aug;117:167-177. doi: 10.1016/j.neuropsychologia.2018.02.016. Epub 2018 Feb 16.

PMID:
29458074
8.

Subthalamic stimulation and neuropsychiatric symptoms in Parkinson's disease: results from a long-term follow-up cohort study.

Abbes M, Lhommée E, Thobois S, Klinger H, Schmitt E, Bichon A, Castrioto A, Xie J, Fraix V, Kistner A, Pélissier P, Seigneuret É, Chabardès S, Mertens P, Broussolle E, Moro E, Krack P.

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):836-843. doi: 10.1136/jnnp-2017-316373. Epub 2018 Feb 7.

PMID:
29436490
9.

Patient Evaluation and Selection for Movement Disorders Surgery: The Changing Spectrum of Indications.

Paschen S, Deuschl G.

Prog Neurol Surg. 2018;33:80-93. doi: 10.1159/000480910. Epub 2018 Jan 12. Review.

PMID:
29332075
10.

Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?

Catalán MJ, Antonini A, Calopa M, Băjenaru O, de Fábregues O, Mínguez-Castellanos A, Odin P, García-Moreno JM, Pedersen SW, Pirtošek Z, Kulisevsky J.

eNeurologicalSci. 2017 Jul 2;8:44-53. doi: 10.1016/j.ensci.2017.06.004. eCollection 2017 Sep. Review.

11.

Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapy.

Rossi PJ, De Jesus S, Hess CW, Martinez-Ramirez D, Foote KD, Gunduz A, Okun MS.

Parkinsonism Relat Disord. 2017 Nov;44:13-17. doi: 10.1016/j.parkreldis.2017.08.006. Epub 2017 Aug 9.

12.

Impulsivity in Parkinson's disease is associated with altered subthalamic but not globus pallidus internus activity.

Rossi PJ, Shute JB, Opri E, Molina R, Peden C, Castellanos O, Foote KD, Gunduz A, Okun MS.

J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):968-970. doi: 10.1136/jnnp-2016-315325. Epub 2017 Aug 19.

PMID:
28822983
13.

Impulse Control and Related Disorders in Parkinson's Disease.

Weintraub D, Claassen DO.

Int Rev Neurobiol. 2017;133:679-717. doi: 10.1016/bs.irn.2017.04.006. Epub 2017 Jun 1. Review.

PMID:
28802938
14.

Deep-Brain Stimulation of the Subthalamic Nucleus Selectively Decreases Risky Choice in Risk-Preferring Rats.

Adams WK, Vonder Haar C, Tremblay M, Cocker PJ, Silveira MM, Kaur S, Baunez C, Winstanley CA.

eNeuro. 2017 Aug 7;4(4). pii: ENEURO.0094-17.2017. doi: 10.1523/ENEURO.0094-17.2017. eCollection 2017 Jul-Aug.

15.

The effect of deep brain stimulation on the non-motor symptoms of Parkinson's disease: a critical review of the current evidence.

Kurtis MM, Rajah T, Delgado LF, Dafsari HS.

NPJ Parkinsons Dis. 2017 Jan 12;3:16024. doi: 10.1038/npjparkd.2016.24. eCollection 2017. Review.

16.

Dopamine agonist withdrawal syndrome (DAWS) in a tertiary Parkinson disease treatment center.

Patel S, Garcia X, Mohammad ME, Yu XX, Vlastaris K, O'Donnell K, Sutton K, Fernandez HH.

J Neurol Sci. 2017 Aug 15;379:308-311. doi: 10.1016/j.jns.2017.06.022. Epub 2017 Jun 16.

PMID:
28716269
17.

Management of impulse control disorders with deep brain stimulation: A double-edged sword.

Kasemsuk C, Oyama G, Hattori N.

J Neurol Sci. 2017 Mar 15;374:63-68. doi: 10.1016/j.jns.2017.01.019. Epub 2017 Jan 7. Review.

PMID:
28126343
18.

Electrode Position and Current Amplitude Modulate Impulsivity after Subthalamic Stimulation in Parkinsons Disease-A Computational Study.

Mandali A, Chakravarthy VS, Rajan R, Sarma S, Kishore A.

Front Physiol. 2016 Nov 29;7:585. eCollection 2016.

19.

Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease.

Merola A, Romagnolo A, Rizzi L, Rizzone MG, Zibetti M, Lanotte M, Mandybur G, Duker AP, Espay AJ, Lopiano L.

J Neurol. 2017 Jan;264(1):40-48. doi: 10.1007/s00415-016-8314-x. Epub 2016 Oct 19.

20.

Deep Brain Stimulation: In Search of Reliable Instruments for Assessing Complex Personality-Related Changes.

Ineichen C, Baumann-Vogel H, Christen M.

Brain Sci. 2016 Sep 7;6(3). pii: E40. doi: 10.3390/brainsci6030040.

Supplemental Content

Loading ...
Support Center